Teva Pharma B.V.
🇳🇱Netherlands
Clinical Trials
18
Active:0
Completed:15
Trial Phases
3 Phases
Phase 2:4
Phase 3:7
Phase 4:1
Drug Approvals
38
EMA:38
Drug Approvals
GoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.)
- Authorization Status
- Authorised
- Approval Date
- Apr 3, 2020
EMA
- Prev
- 1
- 2
- 3
- 4
- Next
Clinical Trials
Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials
Phase 3
7 (58.3%)Phase 2
4 (33.3%)Phase 4
1 (8.3%)Prospective Observational Study in Patients With Metastatic Breast Cancer Treated With Anthracyclines
Completed
- Conditions
- Metastatic Breast Cancer
- First Posted Date
- 2012-03-16
- Last Posted Date
- 2016-04-25
- Lead Sponsor
- Teva Pharma
- Target Recruit Count
- 60
- Registration Number
- NCT01555944
- Locations
- 🇧🇪
ZNA Middelheim, Antwerp, Belgium
🇧🇪Cliniques du Sud Lux - St Joseph, Arlon, Belgium
🇧🇪Imelda, Bonheiden, Belgium
News
No news found